William E. Kennard - 09 Sep 2025 Form 4 Insider Report for METLIFE INC (MET)

Role: Director
Signature: /s/ Taylor McInerney Jansen, Attorney-in-fact
Issuer symbol: MET
Transactions as of: 09 Sep 2025
Net transactions value: +$24,738
Form type: 4
Filing time: 11 Sep 2025, 16:02:10 UTC
Previous filing: 04 Sep 2025
Next filing: 03 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kennard William E	Director	METLIFE, INC., 200 PARK AVENUE, NEW YORK	/s/ Taylor McInerney Jansen, Attorney-in-fact	11 Sep 2025	0001198236

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MET	Common Stock	Award	$24,738	+312	+0.72%	$79.29	43,918	09 Sep 2025	Direct	F1
holding	MET	Common Stock						10	09 Sep 2025	By the MetLife Policyholder Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.
F2	Shares held in trust under the MetLife Policyholder Trust established to hold shares of common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.